Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | IL-17 | 61.0 | 77 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | IL-17 | 51.0 | 62 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | IL-17 | 57.5 | 80 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | IL-17 | 53.0 | 58 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | IL-17 | 59.0 | 55 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | IL-17 | 54.5 | 52 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | IL-17 | 52.0 | 85 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | IL-17 | 63.0 | 69 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | IL-17 | 59.0 | 59 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | IL-17 | 2878.0 | 76 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 2828.0 | 76 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 2862.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 4239.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 5115.0 | 50 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 5428.0 | 79 | |
N2586 | IL-17A | 100 | ng/mL | 1 | IL-17 | 9566.0 | 80 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 5499.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 3361.0 | 71 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 4458.5 | 78 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 4159.0 | 71 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | IL-17 | 4316.0 | 75 | |
RA2159 | 1 | IL-17 | 59.0 | 75 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | IL-17 | 50.0 | 71 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | IL-17 | 53.0 | 68 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | IL-17 | 54.0 | 59 |